21-deacetyldeflazacort: RN given refers to (11beta,16beta)-isomer
ID Source | ID |
---|---|
PubMed CID | 3081431 |
MeSH ID | M0139416 |
Synonym |
---|
21-deacetyldeflazacort |
l 6485 |
t1lwn33j2p , |
21-desacetyldeflazacort |
5'betah-pregna-1,4-dieno(17,16-d)oxazole-3,20-dione, 11beta,21-dihydroxy-2'-methyl- |
21-desdfz |
(11beta,16beta)-11,21-dihydroxy-2'-methyl-5'h-pregna-1,4-dieno(17,16-d)oxazole-3,20-dione |
l-6485 |
deflazacort metabolite ii |
einecs 303-069-8 |
13649-57-5 |
5'h-pregna-1,4-dieno(17,16-d)oxazole-3,20-dione, 11,21-dihydroxy-2'-methyl-, (11beta,16beta)- |
deacetyldeflazacort |
11beta,21-dihydroxy-2'-methyl-16alpha-5'h-pregna-1,4-dieno(17,16-d)oxazole-3,20-dione |
unii-t1lwn33j2p |
21-desacetyl deflazacort |
J-006853 |
(11.beta.,16.beta.)-11,21-dihydroxy-2'-methyl-5'h-pregna-1,4-dieno(17,16-d)oxazole-3,20-dione |
5'h-pregna-1,4-dieno(17,16-d)oxazole-3,20-dione, 11,21-dihydroxy-2'-methyl-, (11.beta.,16.beta.)- |
5'.beta.h-pregna-1,4-dieno(17,16-d)oxazole-3,20-dione, 11.beta.,21-dihydroxy-2'-methyl- |
(1s,2s,4r,8s,9s,11s,12s,13r)-11-hydroxy-8-(2-hydroxyacetyl)-6,9,13-trimethyl-5-oxa-7-azapentacyclo[10.8.0.02,9.04,8.013,18]icosa-6,14,17-trien-16-one |
5'h-pregna-1,4-dieno[17,16-d]oxazole-3,20-dione, 11,21-dihydroxy-2'-methyl-, (11beta,16beta)- |
(11beta,16beta)-11,21-dihydroxy-2'-methyl-5'h-pregna-1,4-dieno[17,16-d]oxazole-3,20-dione |
deflazacort related compound c |
(6ar,6bs,7s,8as,8bs,11ar,12as,12bs)-7-hydroxy-8b-(2-hydroxyacetyl)-6a,8a,10-trimethyl-1,2,6a,6b,7,8,8a,8b,11a,12,12a,12b-dodecahydro-4h-naphtho[2',1':4,5]indeno[1,2-d]oxazol-4-one |
PD044132 |
CS-0018062 |
HY-100085 |
DTXSID201043063 |
AKOS040749909 |
Excerpt | Reference | Relevance |
---|---|---|
" The aim of this study is to evaluate the pharmacokinetic properties of 21-OH DFZ in healthy Chinese volunteers after a single and multiple oral administration of DFZ tablets under fed condition." | ( [Pharmacokinetics of deflazacort tablets in healthy Chinese volunteers]. Ding, L; Ding, W; Li, WB; Lin, HD; Pan, H, 2014) | 0.4 |
" The method was successfully applied to a preclinical pharmacokinetic (PK) study of the six GCs on female nude mice after a single oral dose of 1 mg/kg." | ( Development and validation of a LC-MS/MS method for simultaneous determination of six glucocorticoids and its application to a pharmacokinetic study in nude mice. Guo, Y; Hao, C; Kong, D; Li, J; Tian, X; Xue, J; Yao, Q; Zhou, T, 2020) | 0.56 |
Excerpt | Reference | Relevance |
---|---|---|
"Deflazacort (DFZ, a prodrug) is well absorbed and rapidly metabolized into the active metabolite 21-hydroxydeflazacort (21-OH DFZ) after oral administration." | ( [Pharmacokinetics of deflazacort tablets in healthy Chinese volunteers]. Ding, L; Ding, W; Li, WB; Lin, HD; Pan, H, 2014) | 0.4 |
Timeframe | Studies, This Drug (%) | All Drugs % |
---|---|---|
pre-1990 | 2 (25.00) | 18.7374 |
1990's | 2 (25.00) | 18.2507 |
2000's | 1 (12.50) | 29.6817 |
2010's | 2 (25.00) | 24.3611 |
2020's | 1 (12.50) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.
| This Compound (12.02) All Compounds (24.57) |
Publication Type | This drug (%) | All Drugs (%) |
---|---|---|
Trials | 1 (11.11%) | 5.53% |
Reviews | 0 (0.00%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 8 (88.89%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |